Search

Daniel E. Kolker

Supervisory Patent Examiner (ID: 12246, Phone: (571)272-3181 , Office: P/1644 )

Most Active Art Unit
1649
Art Unit(s)
1645, 1649, 1644, 1646
Total Applications
545
Issued Applications
178
Pending Applications
76
Abandoned Applications
291

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7056418 [patent_doc_number] => 20050277593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Therapeutic uses of Reg protein' [patent_app_type] => utility [patent_app_number] => 11/133465 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6734 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277593.pdf [firstpage_image] =>[orig_patent_app_number] => 11133465 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/133465
Therapeutic uses of Reg protein May 19, 2005 Abandoned
Array ( [id] => 263780 [patent_doc_number] => 07569545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Methods of increasing neurotrophic factor expression' [patent_app_type] => utility [patent_app_number] => 11/134613 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11306 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569545.pdf [firstpage_image] =>[orig_patent_app_number] => 11134613 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/134613
Methods of increasing neurotrophic factor expression May 19, 2005 Issued
Array ( [id] => 6978513 [patent_doc_number] => 20050288231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Biologically active peptides as glutamate receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/127206 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5542 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288231.pdf [firstpage_image] =>[orig_patent_app_number] => 11127206 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127206
Methods of inhibiting glutamate receptors by administering the tripeptide KDI May 11, 2005 Issued
Array ( [id] => 7111700 [patent_doc_number] => 20050209156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients' [patent_app_type] => utility [patent_app_number] => 11/119554 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13972 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209156.pdf [firstpage_image] =>[orig_patent_app_number] => 11119554 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119554
Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients May 1, 2005 Issued
Array ( [id] => 5921266 [patent_doc_number] => 20060239964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Retinal degeneration' [patent_app_type] => utility [patent_app_number] => 11/113821 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4180 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239964.pdf [firstpage_image] =>[orig_patent_app_number] => 11113821 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/113821
Treating retinal degeneration caused by retinal vein occlusion or retinal ischemia Apr 24, 2005 Issued
Array ( [id] => 4927885 [patent_doc_number] => 20080167248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Anti-Aging Effects Of Substance P' [patent_app_type] => utility [patent_app_number] => 11/587595 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2235 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167248.pdf [firstpage_image] =>[orig_patent_app_number] => 11587595 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/587595
Anti-Aging Effects Of Substance P Apr 17, 2005 Abandoned
Array ( [id] => 5865081 [patent_doc_number] => 20060099211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Safer, more potent human immunoglobulin preparations for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/104300 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5233 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099211.pdf [firstpage_image] =>[orig_patent_app_number] => 11104300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/104300
Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease Apr 11, 2005 Abandoned
Array ( [id] => 270207 [patent_doc_number] => 07563441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Anti-P-selectin antibodies' [patent_app_type] => utility [patent_app_number] => 11/102403 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 23549 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563441.pdf [firstpage_image] =>[orig_patent_app_number] => 11102403 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/102403
Anti-P-selectin antibodies Apr 7, 2005 Issued
Array ( [id] => 270209 [patent_doc_number] => 07563443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Monovalent anti-CD40L antibody polypeptides and compositions thereof' [patent_app_type] => utility [patent_app_number] => 11/102512 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 52013 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563443.pdf [firstpage_image] =>[orig_patent_app_number] => 11102512 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/102512
Monovalent anti-CD40L antibody polypeptides and compositions thereof Apr 7, 2005 Issued
Array ( [id] => 252529 [patent_doc_number] => 07579161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Assay methods for suppressor of fused modulation of hedgehog signaling' [patent_app_type] => utility [patent_app_number] => 11/096396 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 29 [patent_no_of_words] => 34143 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579161.pdf [firstpage_image] =>[orig_patent_app_number] => 11096396 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/096396
Assay methods for suppressor of fused modulation of hedgehog signaling Mar 31, 2005 Issued
Array ( [id] => 6958502 [patent_doc_number] => 20050214872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells' [patent_app_type] => utility [patent_app_number] => 11/076793 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3889 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214872.pdf [firstpage_image] =>[orig_patent_app_number] => 11076793 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/076793
Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells Mar 8, 2005 Issued
Array ( [id] => 5247822 [patent_doc_number] => 20070244056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Combination Therapy With Glatiramer Acetate and Riluzole' [patent_app_type] => utility [patent_app_number] => 10/591195 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14102 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244056.pdf [firstpage_image] =>[orig_patent_app_number] => 10591195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591195
Combination Therapy With Glatiramer Acetate and Riluzole Mar 2, 2005 Abandoned
Array ( [id] => 6958467 [patent_doc_number] => 20050214837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Antibody specific for mutant presenilin 1 and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/070405 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214837.pdf [firstpage_image] =>[orig_patent_app_number] => 11070405 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/070405
Antibody specific for mutant presenilin 1 Feb 23, 2005 Issued
Array ( [id] => 5667585 [patent_doc_number] => 20060172935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Screening and therapeutic methods for treating circadian rhythm disorders' [patent_app_type] => utility [patent_app_number] => 11/048649 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 36452 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172935.pdf [firstpage_image] =>[orig_patent_app_number] => 11048649 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/048649
Screening and therapeutic methods for treating circadian rhythm disorders Jan 30, 2005 Abandoned
Array ( [id] => 7069016 [patent_doc_number] => 20050244399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Materials and method for promotion of nerve regeneration' [patent_app_type] => utility [patent_app_number] => 11/051996 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11656 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244399.pdf [firstpage_image] =>[orig_patent_app_number] => 11051996 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/051996
Method for promoting axonal outgrowth in damaged nerves Jan 30, 2005 Issued
Array ( [id] => 5045700 [patent_doc_number] => 20070264373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Toxin Induced Sympathectomy' [patent_app_type] => utility [patent_app_number] => 10/587535 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6236 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264373.pdf [firstpage_image] =>[orig_patent_app_number] => 10587535 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/587535
Toxin Induced Sympathectomy Jan 25, 2005 Abandoned
Array ( [id] => 7219606 [patent_doc_number] => 20050260616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Nucleotide and protein sequences of Nogo genes and methods based thereon' [patent_app_type] => utility [patent_app_number] => 11/044899 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 31213 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260616.pdf [firstpage_image] =>[orig_patent_app_number] => 11044899 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/044899
Methods of making antibodies that bind Nogo Jan 25, 2005 Issued
Array ( [id] => 5814790 [patent_doc_number] => 20060084597 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2006-04-20 [patent_title] => 'USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY' [patent_app_type] => utility [patent_app_number] => 10/518159 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14594 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0084/20060084597.pdf [firstpage_image] =>[orig_patent_app_number] => 10518159 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/518159
USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY Jan 17, 2005 Abandoned
Array ( [id] => 7005079 [patent_doc_number] => 20050170392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'OAT3 transporters expressed in blood brain barrier cells' [patent_app_type] => utility [patent_app_number] => 11/027581 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15201 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170392.pdf [firstpage_image] =>[orig_patent_app_number] => 11027581 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/027581
OAT3 transporters expressed in blood brain barrier cells Dec 29, 2004 Abandoned
Array ( [id] => 7005080 [patent_doc_number] => 20050170393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'OATPB transporters expressed in blood brain barrier cells' [patent_app_type] => utility [patent_app_number] => 11/027694 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14812 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170393.pdf [firstpage_image] =>[orig_patent_app_number] => 11027694 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/027694
OATPB transporters expressed in blood brain barrier cells Dec 29, 2004 Abandoned
Menu